Showing results (131-140 of 299) with videos related to

Sort By:
Pageof 30
Cancer Chemotherapy and Pharmacology|November 8, 2011
A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)Jordi Rodon, Charlotte D Jacobs, Quincy Chu, et al.
Chest|July 6, 2013
miR-1 induces growth arrest and apoptosis in malignant mesotheliomaYue Xu, Ming Zheng, Robert E Merritt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2018
Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter StudyLeora Horn, Jeffrey R Infante, Karen L Reckamp, et al.
Journal of Patient-Reported Outcomes|September 15, 2021
Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancerOlga Generalova, Mohana Roy, Evan Hall, et al.
Circulation Research|February 11, 2025
Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy MyocarditisYuhsin Vivian Huang, Yin Sun, Harrison Chou, et al.
Clinical Lung Cancer|July 14, 2023
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never SmokedJ Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, et al.
Cardiology Clinics|November 17, 2024
Classes of Antineoplastic Agents Associated with Increased Risk of Cancer Therapy-associated Hypertension and Management StrategiesHoda Sayegh, Alexia Zagouras, Joel W Neal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2017
Risk Stratification for Second Primary Lung CancerSummer S Han, Gabriel A Rivera, Martin C Tammemägi, et al.
Current Atherosclerosis Reports|November 1, 2016
Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients?Ange Wang, Heather A Wakelee, Aaron K Aragaki, et al.
Annals of Internal Medicine|December 15, 2025
Eligibility and Prognostic Performance of Smoking Duration-Based Versus Pack-Year-Based U.S. National Lung Cancer Screening Criteria Across Racial and Ethnic GroupsChloe C Su, Victoria Y Ding, Kevin Ten Haaf, et al.
Pageof 30